Skip to content

Trial of PermaNet 3-barrier bednets as part of an operational distribution programme in Haut-Katanga province, Democratic Republic of Congo

Trial of PermaNet 3-barrier bednets as part of an operational distribution programme in Haut-Katanga province, DRC (BBnets)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14487329
Enrollment
8856
Registered
2024-08-14
Start date
2023-12-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of malaria in antenatal clinic visitors Infections and Infestations

Interventions

This two-armed study intervention involves the distribution of two types of insecticide-treated bednets to compare PermaNet 3 with PermaNet 3-barrier bednets (P3-BBnets). The study arms are represente

Sponsors

Liverpool School of Tropical Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant women visiting their first antenatal clinic

Exclusion criteria

Exclusion criteria: 1. Young adolescents (<15 years) 2. Women presenting with symptoms of severe malaria 3. Women suffering from other illnesses requiring prompt treatment 4. Limited capacity to consent assessed by understanding of procedures and requirements of the study

Design outcomes

Primary

MeasureTime frame
Malaria prevalence in antenatal clinic visitors measured using a rapid diagnostic test (RDT) for malaria at one timepoint when visitors attend their first antenatal clinic

Secondary

MeasureTime frame
User perception and acceptance of barrier bednets measured using a bespoke questionnaire made for the study at the time when the participants are tested for malaria

Countries

Congo, Democratic Republic

Contacts

Public ContactDavid Weetman
david.weetman@lstmed.ac.uk+44 (0)151 7053225

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026